These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17678742)

  • 1. The effect of drug-eluting stents on collateral coronary flow.
    di Mario C; Dimopoulos K
    J Am Coll Cardiol; 2007 Aug; 50(6):560; author reply 561. PubMed ID: 17678742
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stent implantation and coronary collateral growth attenuation: is drug the only culprit?
    Parent MC; Rinfret S
    J Am Coll Cardiol; 2007 Aug; 50(6):560-1; author reply 561. PubMed ID: 17678743
    [No Abstract]   [Full Text] [Related]  

  • 3. Attenuated coronary collateral function after drug-eluting stent implantation: a new downside of drug-eluting stents?
    Kern MJ
    J Am Coll Cardiol; 2007 Jan; 49(1):21-2. PubMed ID: 17207717
    [No Abstract]   [Full Text] [Related]  

  • 4. Left main drug-eluting stents: natural progression or a bridge too far?
    Stone GW; Moses JW; Leon MB
    J Am Coll Cardiol; 2007 Aug; 50(6):498-500. PubMed ID: 17678731
    [No Abstract]   [Full Text] [Related]  

  • 5. Late thrombosis and drug-eluting stents.
    Williams D
    Med Device Technol; 2006; 17(9):8, 10. PubMed ID: 17240679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
    Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
    J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
    Obata JE; Kitta Y; Takano H; Kodama Y; Nakamura T; Mende A; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Yano T; Kugiyama K
    J Am Coll Cardiol; 2007 Oct; 50(14):1305-9. PubMed ID: 17903627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCAI statement on drug-eluting stents: practice and health care delivery implications.
    Hodgson JM; King SB; Feldman T; Cowley MJ; Klein LW; Babb JD;
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):397-9. PubMed ID: 12594710
    [No Abstract]   [Full Text] [Related]  

  • 10. Stenting an aorto-ostial stenosis of the right coronary artery.
    Villa E; Pacini D; Di Bartolomeo R
    Int J Cardiol; 2006 Jan; 106(3):413-4. PubMed ID: 16337057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
    Kumar R; Lee TT; Jeremias A; Ruisi CP; Sylvia B; Magallon J; Kirtane AJ; Bigelow B; Abrahamson M; Pinto DS; Ho KK; Cohen DJ; Carrozza JP; Cutlip DE
    Am J Cardiol; 2007 Oct; 100(8):1187-91. PubMed ID: 17920355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
    Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel side branch ostial stent.
    Chen SL; Lv SZ; Kwan TW
    J Interv Cardiol; 2009 Apr; 22(2):145-9. PubMed ID: 19379473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double barrel stenting of the left main: proceed with caution.
    Kaplan AV
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):216-7. PubMed ID: 17253605
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective on bifurcation PCI.
    Chen SL; Louvard Y; Runlin G
    J Interv Cardiol; 2009 Apr; 22(2):99-109. PubMed ID: 19379466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A
    J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic reactions following implantation of drug-eluting stents: a manifestation of Kounis syndrome?
    Kounis NG; Kounis GN; Kouni SN; Soufras GD; Niarchos C; Mazarakis A
    J Am Coll Cardiol; 2006 Aug; 48(3):592-3; author reply 593-4. PubMed ID: 16875994
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse events and Cypher stents.
    FDA Consum; 2004; 38(1):6. PubMed ID: 15032191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.